{"id":"placebo-vaginal-insert","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1614641","moleculeType":"Small molecule","molecularWeight":"285.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are inert products designed to match the appearance and administration route of an active investigational drug, allowing for blinded comparison in clinical studies. In this case, the vaginal insert format mimics the delivery method of the active comparator while containing no therapeutic agent. Placebo controls are essential for establishing efficacy and safety of novel therapeutics.","oneSentence":"A placebo vaginal insert contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:29:04.803Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT02518594","phase":"PHASE3","title":"A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2015-11-13","conditions":"Short Cervical Length","enrollment":1311},{"nctId":"NCT07109869","phase":"PHASE3","title":"Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis","status":"RECRUITING","sponsor":"pH-D Feminine Health LLC","startDate":"2025-08-08","conditions":"Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital, Vulvovaginal Candidiasis (VVC)","enrollment":400},{"nctId":"NCT06491446","phase":"PHASE1, PHASE2","title":"Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts","status":"ACTIVE_NOT_RECRUITING","sponsor":"Antiva Biosciences","startDate":"2024-03-27","conditions":"Human Papillomavirus Infection","enrollment":141},{"nctId":"NCT07418957","phase":"PHASE3","title":"Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial Vaginosis","status":"COMPLETED","sponsor":"Guangdong Longchuangji Pharmaceutical Co., Ltd.","startDate":"2024-06-12","conditions":"Bacterial Vaginosis (BV)","enrollment":402},{"nctId":"NCT07302035","phase":"PHASE1","title":"A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-12","conditions":"Bacterial Vaginosis","enrollment":30},{"nctId":"NCT06519994","phase":"PHASE2","title":"Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2025-01-22","conditions":"Human Immunodeficiency Virus, Human Papillomavirus, Cervical Precancer","enrollment":120},{"nctId":"NCT07288021","phase":"PHASE4","title":"Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)","status":"RECRUITING","sponsor":"Bnai Zion Medical Center","startDate":"2024-02-05","conditions":"Labor, Induced","enrollment":200},{"nctId":"NCT04266275","phase":"PHASE2","title":"Topical Curcumin for HPV Related Cervical Disease","status":"NOT_YET_RECRUITING","sponsor":"Lisa Flowers","startDate":"2026-03","conditions":"Neoplasm Cervix","enrollment":200},{"nctId":"NCT04098744","phase":"PHASE2","title":"Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)","status":"RECRUITING","sponsor":"Frantz Viral Therapeutics, LLC","startDate":"2020-09-09","conditions":"CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia","enrollment":78},{"nctId":"NCT06087913","phase":"PHASE1","title":"Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2023-11-08","conditions":"Safety Issues","enrollment":68},{"nctId":"NCT06469164","phase":"PHASE1","title":"A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2024-07-01","conditions":"Bacterial Vaginosis","enrollment":102},{"nctId":"NCT04833140","phase":"PHASE3","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-12-02","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":60},{"nctId":"NCT06986031","phase":"PHASE2","title":"PKB171 Against Placebo in Couples With Asthenozoospermia Who Wish to Conceive","status":"TERMINATED","sponsor":"Prokrea BCN, S.L.","startDate":"2017-05-08","conditions":"Infertility, Male","enrollment":60},{"nctId":"NCT04963179","phase":"NA","title":"PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Womed","startDate":"2021-11-29","conditions":"Asherman Syndrome, Intrauterine Adhesion","enrollment":160},{"nctId":"NCT06864078","phase":"NA","title":"IUCD Insertion in Patients Delivered by Cesarean Section","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2023-09-10","conditions":"IUD","enrollment":128},{"nctId":"NCT06163274","phase":"EARLY_PHASE1","title":"Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Rings","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2024-02-28","conditions":"Safety, Acceptability","enrollment":93},{"nctId":"NCT05540353","phase":"NA","title":"Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis.","status":"TERMINATED","sponsor":"Medstar Health Research Institute","startDate":"2023-05-02","conditions":"Endometriosis, Dyspareunia, Pelvic Pain","enrollment":6},{"nctId":"NCT06046053","phase":"EARLY_PHASE1","title":"MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films","status":"COMPLETED","sponsor":"Rohan, Lisa, PhD","startDate":"2023-10-18","conditions":"Safety, Acceptability, Usability","enrollment":100},{"nctId":"NCT06007027","phase":"NA","title":"Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-12-01","conditions":"Genitourinary Syndrome of Menopause","enrollment":60},{"nctId":"NCT02944578","phase":"PHASE2","title":"Topical Curcumin for Precancer Cervical Lesions","status":"TERMINATED","sponsor":"Lisa Flowers","startDate":"2017-11-20","conditions":"Neoplasms","enrollment":7},{"nctId":"NCT05378269","phase":"PHASE1, PHASE2","title":"Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA","status":"COMPLETED","sponsor":"Daré Bioscience, Inc.","startDate":"2021-11-22","conditions":"Vulvar Atrophy","enrollment":17},{"nctId":"NCT04982692","phase":"PHASE3","title":"A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2021-09-13","conditions":"Postmenopausal Vulvovaginal Atrophy","enrollment":417},{"nctId":"NCT01938092","phase":"PHASE2","title":"Vaginal Diazepam for the Treatment of Female Pelvic Pain","status":"COMPLETED","sponsor":"Raymond Foster","startDate":"2013-09","conditions":"Pelvic Floor Disorders, Pelvic Pain","enrollment":50},{"nctId":"NCT02573051","phase":"PHASE2","title":"Termination Of Anembryonic Pregnancy","status":"WITHDRAWN","sponsor":"Assiut University","startDate":"2015-06","conditions":"Missed Abortion","enrollment":""},{"nctId":"NCT05713435","phase":"NA","title":"Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2022-12-27","conditions":"Genitourinary Syndrome of Menopause","enrollment":162},{"nctId":"NCT02275546","phase":"PHASE3","title":"Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2014-12-11","conditions":"Contraception: Optional Applicator for Insertion of Vaginal Ring","enrollment":164},{"nctId":"NCT05617820","phase":"PHASE3","title":"Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2022-11-15","conditions":"Dyspareunia","enrollment":1050},{"nctId":"NCT02460302","phase":"PHASE2","title":"Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy","status":"WITHDRAWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2016-12","conditions":"Atrophic Vaginitis, Menopause, Vulvovaginal Atrophy","enrollment":""},{"nctId":"NCT05757011","phase":"NA","title":"the Effect of Pre-sacral Nerve Block on Post-operative Pain Following Laparoscopic Hysterectomy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-01-05","conditions":"Gynecology","enrollment":40},{"nctId":"NCT05629481","phase":"NA","title":"A Study of Fractional Carbon Dioxide Laser Treatment for Female Stress Urinary Incontinence","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2022-04-20","conditions":"Stress Urinary Incontinence","enrollment":120},{"nctId":"NCT03930745","phase":"PHASE2","title":"Suppression Of Bacterial Vaginosis (BV) [SUBVert]","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-09-09","conditions":"Bacterial Vaginosis","enrollment":81},{"nctId":"NCT01448616","phase":"PHASE4","title":"Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding","status":"COMPLETED","sponsor":"University of Washington","startDate":"2012-02","conditions":"Herpes Simplex Type II","enrollment":73},{"nctId":"NCT03316950","phase":"NA","title":"Radiofrequency and Hybrid Fractional Laser for Vaginal Rejuvenation","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-06-15","conditions":"Vaginal Atrophy","enrollment":52},{"nctId":"NCT04500028","phase":"PHASE4","title":"Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-08-01","conditions":"IUCD Complication","enrollment":220},{"nctId":"NCT05341856","phase":"EARLY_PHASE1","title":"Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL","status":"UNKNOWN","sponsor":"Al-Azhar University","startDate":"2022-05-01","conditions":"Recurrent Pregnancy Loss","enrollment":60},{"nctId":"NCT01959464","phase":"PHASE4","title":"Sexual Absorption of Vaginal Progesterone","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2008-11","conditions":"Infertility, Pregnancy","enrollment":20},{"nctId":"NCT04391036","phase":"NA","title":"Randomized Cross-Over Study of Self-Insertion of Two Placebo Vaginal Film Formulations","status":"COMPLETED","sponsor":"Katherine Bunge","startDate":"2020-07-14","conditions":"Safety, Acceptability","enrollment":30},{"nctId":"NCT04021966","phase":"NA","title":"Use of Fractional CO2 Laser for the Treatment of Vulvovaginal Atrophy: a Double-blinded Randomized Placebo-controlled Clinical Trial.","status":"COMPLETED","sponsor":"prof. dr. Jan Deprest","startDate":"2019-08-01","conditions":"Vulvovaginal Atrophy","enrollment":60},{"nctId":"NCT04339049","phase":"PHASE3","title":"Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-05-01","conditions":"Contraception","enrollment":147},{"nctId":"NCT01490671","phase":"PHASE2","title":"Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT04500522","phase":"PHASE4","title":"Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":150},{"nctId":"NCT04500015","phase":"PHASE4","title":"Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":130},{"nctId":"NCT04499989","phase":"PHASE4","title":"Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":220},{"nctId":"NCT03547778","phase":"PHASE4","title":"Misoprostol in Office Hysteroscopy and Endometrial Biopsy","status":"WITHDRAWN","sponsor":"University of South Florida","startDate":"2018-09-01","conditions":"Office Hysteroscopy and Endometrial Biopsy","enrollment":""},{"nctId":"NCT04339348","phase":"PHASE3","title":"Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-04-30","conditions":"Contraception","enrollment":210},{"nctId":"NCT04085757","phase":"PHASE3","title":"Optimal Timing of Dinoprostone Administration Prior to Office Hysteroscopy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-15","conditions":"Dinoprostone Timing","enrollment":180},{"nctId":"NCT03287232","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2017-10-16","conditions":"Hypoactive Sexual Desire Disorder","enrollment":653},{"nctId":"NCT04312048","phase":"PHASE3","title":"the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-04-15","conditions":"IUD Insertion Pain","enrollment":110},{"nctId":"NCT03823560","phase":"NA","title":"Performance and Safety of Class IIb MD Celegyn® in VVA","status":"UNKNOWN","sponsor":"Nathura S.p.A","startDate":"2019-09-24","conditions":"Vulvovaginal Atrophy","enrollment":96},{"nctId":"NCT04574999","phase":"PHASE3","title":"Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.","status":"COMPLETED","sponsor":"Italfarmaco S.A","startDate":"2008-01-25","conditions":"Vaginal Atrophy","enrollment":167},{"nctId":"NCT03067727","phase":"PHASE3","title":"A Randomised Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-04-03","conditions":"Cervical Ripening","enrollment":114},{"nctId":"NCT03166111","phase":"PHASE3","title":"Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-09-01","conditions":"Contraception","enrollment":216},{"nctId":"NCT04044079","phase":"PHASE4","title":"Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-08-20","conditions":"Office Hysteroscopy","enrollment":150},{"nctId":"NCT04080323","phase":"PHASE3","title":"Single-dose Vaginal Dinoprostone and Hysterectomy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-25","conditions":"Hysterectomy","enrollment":118},{"nctId":"NCT04505917","phase":"NA","title":"Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":200},{"nctId":"NCT04079140","phase":"PHASE4","title":"Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-15","conditions":"IUD Insertion Pain","enrollment":130},{"nctId":"NCT03619005","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-13","conditions":"Hypoactive Sexual Desire Disorder (HSDD)","enrollment":""},{"nctId":"NCT04273984","phase":"PHASE4","title":"Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-03-01","conditions":"Intra-uterine Device Complication","enrollment":180},{"nctId":"NCT03686085","phase":"PHASE3","title":"Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-09-30","conditions":"Intrauterine Device","enrollment":200},{"nctId":"NCT04080336","phase":"PHASE4","title":"Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Nulliparous Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-10","conditions":"IUD Insertion Complication","enrollment":129},{"nctId":"NCT04340778","phase":"PHASE3","title":"Comparative Safety and Efficacy of Vaginal Dinoprostone Versus Lidocaine-prilocaine Cream in Copper IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-04-30","conditions":"Contraception","enrollment":210},{"nctId":"NCT04339361","phase":"PHASE4","title":"Comparative Efficacy of Lidocaine Spray Versus Vaginal Dinoprostone in IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-04-25","conditions":"Contraception","enrollment":111},{"nctId":"NCT04301349","phase":"PHASE3","title":"Dinoprostone vs Misoprostol Before LNG-IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-15","conditions":"IUD Insertion Pain","enrollment":200},{"nctId":"NCT04046302","phase":"PHASE4","title":"Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-08-30","conditions":"IUD Insertion","enrollment":160},{"nctId":"NCT02367833","phase":"PHASE4","title":"Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis","status":"COMPLETED","sponsor":"Penn State University","startDate":"2015-01","conditions":"Bone; Disorder, Development and Growth","enrollment":60},{"nctId":"NCT03040011","phase":"PHASE1, PHASE2","title":"Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery","status":"COMPLETED","sponsor":"Lauren Giugale, MD","startDate":"2017-06-01","conditions":"Pelvic Organ Prolapse, Surgery, Postoperative Pain","enrollment":79},{"nctId":"NCT04045548","phase":"PHASE4","title":"Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-08-10","conditions":"Intrauterine Device","enrollment":200},{"nctId":"NCT03537092","phase":"NA","title":"A Study of the Safety and Acceptability of a Placebo Vaginal Film: FAME101","status":"COMPLETED","sponsor":"Katherine Bunge","startDate":"2018-05-22","conditions":"Safety of Vaginal Film Use","enrollment":64},{"nctId":"NCT02813681","phase":"NA","title":"Ultrasound-Guided Landmark and Epidural Site Pain","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2014-05","conditions":"Back Pain, Epidural Analgesia, Obstetric","enrollment":80},{"nctId":"NCT02967510","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"ITF Research Pharma, S.L.U.","startDate":"2016-10","conditions":"Vaginal Atrophy","enrollment":283},{"nctId":"NCT04080349","phase":"PHASE4","title":"Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only by Cesarean Delivery","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-09-10","conditions":"IUD Pain","enrollment":300},{"nctId":"NCT02413008","phase":"PHASE2","title":"A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting","status":"COMPLETED","sponsor":"ITF Research Pharma, S.L.U.","startDate":"2015-10-16","conditions":"Vaginal Atrophy","enrollment":61},{"nctId":"NCT04042974","phase":"PHASE4","title":"Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-08-10","conditions":"Hysteroscopy","enrollment":100},{"nctId":"NCT02237950","phase":"PHASE3","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","status":"COMPLETED","sponsor":"Starpharma Pty Ltd","startDate":"2014-10-13","conditions":"Bacterial Vaginosis","enrollment":586},{"nctId":"NCT02738203","phase":"PHASE3","title":"Self-Administered Lidocaine Gel for Pain Management With IUD Insertion","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-06-01","conditions":"IUD Insertion","enrollment":220},{"nctId":"NCT03939663","phase":"PHASE2","title":"Role of Vaginal Misoprostol Prior to IUCD Insertion in Women Who Delivered Only by Elective Caesarean Section.","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2018-07-01","conditions":"IUD Insertion Complication","enrollment":210},{"nctId":"NCT01490073","phase":"NA","title":"The Effect of Nitroglycerin on the Intrauterine Device (IUD) Insertion Experience in Nulliparous Women","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2012-03-01","conditions":"Contraception, Pain","enrollment":24},{"nctId":"NCT03683914","phase":"PHASE4","title":"Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-09-30","conditions":"Office Hysteroscopy","enrollment":102},{"nctId":"NCT03782480","phase":"PHASE3","title":"Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy","status":"UNKNOWN","sponsor":"Center for Vulvovaginal Disorders","startDate":"2019-03-02","conditions":"Menopause, Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy","enrollment":40},{"nctId":"NCT03790371","phase":"PHASE3","title":"Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-10-01","conditions":"Contraception","enrollment":90},{"nctId":"NCT01753102","phase":"PHASE3","title":"Efficacy and Safety Of Spil's Estradiol Vaginal Tablet","status":"TERMINATED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2012-11-06","conditions":"Vulvar Atrophy, Vaginal Atrophy","enrollment":49},{"nctId":"NCT02006264","phase":"PHASE1","title":"Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2013-11-19","conditions":"HIV","enrollment":30},{"nctId":"NCT02762617","phase":"PHASE1","title":"Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002)","status":"TERMINATED","sponsor":"Marla Keller","startDate":"2017-02-24","conditions":"Healthy, HIV","enrollment":17},{"nctId":"NCT02296099","phase":"PHASE4","title":"Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence","status":"COMPLETED","sponsor":"TriHealth Inc.","startDate":"2014-11","conditions":"Urinary Incontinence, Stress","enrollment":114},{"nctId":"NCT03587077","phase":"NA","title":"Pain Relief During IUD Insertion in Women Delivered Only by Elective Cesarean Section","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-09","conditions":"IUD Insertion Complication","enrollment":113},{"nctId":"NCT02516202","phase":"PHASE3","title":"The Vaginal Health Trial","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2016-04","conditions":"Atrophy of Vagina, Menopause, Dyspareunia (Female)","enrollment":302},{"nctId":"NCT02908503","phase":"NA","title":"Vaginal Film Administration and Placement Study: FLAG","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2016-07","conditions":"Healthy Women","enrollment":32},{"nctId":"NCT02236156","phase":"PHASE3","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","status":"COMPLETED","sponsor":"Starpharma Pty Ltd","startDate":"2014-10-03","conditions":"Bacterial Vaginosis","enrollment":637},{"nctId":"NCT03427216","phase":"NA","title":"Baclofen/Diazepam Supps for Treatment of Pelvic Floor Myalgia","status":"UNKNOWN","sponsor":"Dr. John A. Thiel Medical Professional Corporation","startDate":"2018-09-01","conditions":"Pelvic Floor Dyssynergia","enrollment":60},{"nctId":"NCT02602366","phase":"NA","title":"The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy","status":"COMPLETED","sponsor":"CONRAD","startDate":"2016-06-06","conditions":"HIV, Contraception","enrollment":422},{"nctId":"NCT03490617","phase":"PHASE3","title":"Misoprostol Prior to IUD Insertion in Nullipara","status":"COMPLETED","sponsor":"Instituto Materno Infantil Prof. Fernando Figueira","startDate":"2009-07","conditions":"Family Planning","enrollment":179},{"nctId":"NCT01724242","phase":"PHASE2, PHASE3","title":"Vaginal DHEA for Women After Breast Cancer","status":"WITHDRAWN","sponsor":"Hadassah Medical Organization","startDate":"2013-02","conditions":"Vaginal Dryness, Breast Cancer, Urinary Incontinence","enrollment":""},{"nctId":"NCT03081442","phase":"PHASE4","title":"Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-11","conditions":"Contraceptive Device; Complications","enrollment":120},{"nctId":"NCT02569697","phase":"PHASE1","title":"Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms","status":"COMPLETED","sponsor":"CONRAD","startDate":"2015-10","conditions":"HIV","enrollment":50},{"nctId":"NCT01989663","phase":"PHASE1","title":"A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-11","conditions":"HIV","enrollment":78},{"nctId":"NCT00685113","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2008-05","conditions":"Overactive Bladder","enrollment":1104},{"nctId":"NCT02522130","phase":"NA","title":"Different Analgesics Prior to Intrauterine Device (IUD) Insertion: Is There Any Evidence?","status":"UNKNOWN","sponsor":"Al Hayat National Hospital","startDate":"2015-07","conditions":"IUD Insertion Complication","enrollment":200},{"nctId":"NCT02534779","phase":"NA","title":"Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products","status":"COMPLETED","sponsor":"CONRAD","startDate":"2015-08","conditions":"Vaginal Diseases","enrollment":49},{"nctId":"NCT02412033","phase":"PHASE1","title":"Misoprostol Prior to Intrauterine Contraceptive Device Insertion","status":"COMPLETED","sponsor":"Assiut University","startDate":"2016-03","conditions":"Pain Prior to IUD Insertion","enrollment":140},{"nctId":"NCT00441298","phase":"PHASE2","title":"Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV","status":"COMPLETED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2007-05","conditions":"HIV Infections","enrollment":889}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo vaginal insert","genericName":"Placebo vaginal insert","companyName":"Frantz Viral Therapeutics, LLC","companyId":"frantz-viral-therapeutics-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}